Sponsor: 
GlaxoSmithKline Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Combination vaccines

Registered for primary immunisation in infants aged 2–12 months and as a booster in children aged 15 months to 6 years.

DTPa — diphtheria-tetanus-acellular pertussis combination vaccine

Each 0.5 mL monodose vial or pre-filled syringe contains:

  • ≥30 IU diphtheria toxoid
  • ≥40 IU tetanus toxoid
  • 25 µg pertussis toxoid
  • 25 µg filamentous haemagglutinin
  • 8 µg pertactin

Adsorbed onto 0.5 mg aluminium as aluminium hydroxide.

For full details, refer to the product information and consumer medicine information sheets for Infanrix vaccine available on the TGA website.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018

Definitions

DTPa
diphtheria-tetanus-acellular pertussis vaccine
IU
international units